# FDA Warning Letter: Kobayashi Healthcare International, Inc.
> 2023-01-31 · Office of Pharmaceutical Quality · `40bebb9f18c8439f`
## Letter
- **Company:** Kobayashi Healthcare International, Inc.
- **Posted Date:** 2023-01-31
- **Letter Issue Date:** 2023-01-27
- **Issuing Office:** Office of Pharmaceutical Quality
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*